In Situ Hybridization (ISH) Market to 2027 - Global Analysis and Forecasts by Technology (Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization); By Application (Immunology, Microbiology, Cancer Diagnostic, Neuroscience and Infectious Diseases); and By End User (Biotechnology/Pharmaceutical Companies, Academic & Research Institutes and Molecular Diagnostic Labs)
Report Code: TIPHE100001167 No. of Pages: 150 Category: Biotechnology Status: Upcoming
In Situ Hybridization (ISH) is a process that utilizes labeled DNA or RNA probes to detect complementary DNA or RNA sites in a piece of tissue or in cytological preparation. This technique allows to gain temporary and three-dimensional information about gene expression and genetic site. The in-situ hybridization is similar to the blot hybridization.
The market for in situ hybridization (ISH) is expected to grow with a significant rate due to the factors such as, high prevalence of the cancer and infectious diseases, increase in the neuroscience studies, rise in the study and development of the neuroscience, immunology, microbiology and cytology. As the regulatory bodies are funding enormously for the healthcare industry, the players are receiving great opportunities to grow their market share in the biotechnological industry.
The “Global In Situ Hybridization (ISH) Market Analysis to 2027” is a specialized and in-depth study of the In Situ Hybridization (ISH) industry with a focus on the global market trend. The report aims to provide an overview of global in situ hybridization (ISH) market with detailed market segmentation by technology, application, end user and geography. The global in situ hybridization (ISH) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The in situ hybridization (ISH) market is segmented based on technology as, chromogenic in situ hybridization (CISH) and fluorescence in situ hybridization (FISH). The application segment is classified as, immunology, microbiology, cancer diagnostic, neuroscience, and infectious diseases. The end user is segment is classified as biotechnology/ pharmaceutical companies, academic & research institutes, molecular diagnostic labs.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global In Situ Hybridization (ISH) market based on, technology, application and end user. It also provides market size and forecast till 2027 for overall in situ hybridization (ISH) market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is anticipated as the largest market for in situ hybridization (ISH) market in the global scenario as the rise in the biological and clinical research for cancer diagnostic are been conducted by the various pharmaceutical and biotechnological companies. Filing for the patent right motivates the small companies to conduct more research for the various techniques that will give them more opportunities to expand their product portfolio and also to expand their geographic presence.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key In Situ Hybridization (ISH) manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Abbott, ThermoFisher Scientific, Inc., PerkinElmer Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher, BioGenex, Bio SB, Exiqon (QIAGEN), and Oxford Gene Technology
1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 In Situ Hybridization (ISH) Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 In Situ Hybridization (ISH) Market – By Technology
3.2.2 In Situ Hybridization (ISH) Market – By Application
3.2.3 In Situ Hybridization (ISH) Market – By End User
3.2.4 In Situ Hybridization (ISH) Market – By Region
3.3 PEST Analysis
3.3.1 US – PEST Analysis
3.3.2 Europe – PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East and Africa – PEST Analysis
3.3.5 South and Central America – PEST Analysis
4 In Situ Hybridization (ISH) Market – Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 In Situ Hybridization (ISH) Market - Global Analysis
5.1 Global In Situ Hybridization (ISH) Market Overview
5.2 Global In Situ Hybridization (ISH) Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trial Analysis
5.6 Expert Opinions
6 In Situ Hybridization (ISH) Market Revenue and Forecasts to 2027 – Technology (US$ Mn)
6.1 Overview
6.2 Technology Market Forecasts and Analysis
6.3 Chromogenic In Situ Hybridization (CISH) Market
6.3.1 Overview
6.3.2 Chromogenic In Situ Hybridization (CISH) Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Fluorescence In Situ Hybridization (FISH) Market
6.4.1 Overview
6.4.2 Fluorescence In Situ Hybridization (FISH) Market Revenue Forecasts and Analysis (US$ Mn)
6.4.3 DNA FISH Market
6.4.3.1 Overview
6.4.3.2 DNA FISH Market Revenue Forecast and Analysis (US$ Mn)
6.4.4 RNA FISH Market
6.4.4.1 Overview
6.4.4.2 RNA FISH Market Revenue Forecast and Analysis (US$ Mn)
7 In Situ Hybridization (ISH) Market Revenue and Forecasts to 2027 – Application (US$ Mn)
7.1 Overview
7.2 Application Market Forecasts and Analysis
7.3 Immunology Market
7.3.1 Overview
7.3.2 Immunology Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Microbiology Market
7.4.1 Overview
7.4.2 Microbiology Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Cancer Diagnostic Market
7.5.1 Overview
7.5.2 Cancer Diagnostic Market Revenue Forecasts and Analysis (US$ Mn)
7.6 Infectious Diseases Market
7.6.1 Overview
7.6.2 Infectious Diseases Market Revenue Forecasts and Analysis (US$ Mn)
7.7 Neuroscience Market
7.7.1 Overview
7.7.2 Neuroscience Market Revenue Forecasts and Analysis (US$ Mn)
8 In Situ Hybridization (ISH) Market Revenue and Forecasts to 2027 – End User (US$ Mn)
8.1 Overview
8.2 End user Market Forecasts and Analysis
8.3 Biotechnology/Pharmaceutical Companies Market
8.3.1 Overview
8.3.2 Biotechnology/Pharmaceutical Companies Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Academic & Research Institutes Market
8.4.1 Overview
8.4.2 Academic & Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Molecular Diagnostic Labs Market
8.5.1 Overview
8.5.2 Molecular Diagnostic Labs Market Revenue Forecasts and Analysis (US$ Mn)
9 North America In Situ Hybridization (ISH) Market Revenue and Forecasts to 2027 – Country Analysis
9.1 North America In Situ Hybridization (ISH) Market Overview
9.2 North America In Situ Hybridization (ISH) Market Revenue Forecasts and Analysis (US$ Mn)
9.3 North America In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
9.3.1 North America Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
9.4 North America In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
9.5 North America In Situ Hybridization (ISH) Market Forecasts and Analysis – By End User (US$ Mn)
9.6 North America Market Forecasts and Analysis – By Country
9.7 US Market Overview
9.7.1 US In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
9.7.1.1 US Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
9.7.2 US In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
9.7.3 US In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
9.8 Canada Market Overview
9.8.1 Canada In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
9.8.1.1 Canada Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
9.8.2 Canada In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
9.8.3 Canada In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
9.9 Mexico Market Overview
9.9.1 Mexico In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
9.9.1.1 Mexico Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
9.9.2 Mexico In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
9.9.3 Mexico In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
10 Europe In Situ Hybridization (ISH) Market Revenue and Forecasts to 2027 – Country Analysis
10.1 Europe In Situ Hybridization (ISH) Market Overview
10.2 Europe In Situ Hybridization (ISH) Market Revenue Forecasts and Analysis (US$ Mn)
10.3 Europe In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
10.3.1 Europe Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
10.4 Europe In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
10.5 Europe In Situ Hybridization (ISH) Market Forecasts and Analysis – By End User (US$ Mn)
10.6 Europe Market Forecasts and Analysis – By Country
10.7 UK Market Overview
10.7.1 UK In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
10.7.1.1 UK Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
10.7.2 UK In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
10.7.3 UK In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
10.8 Germany Market Overview
10.8.1 Germany In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
10.8.1.1 Germany Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
10.8.2 Germany In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
10.8.3 Germany In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
10.9 France Market Overview
10.9.1 France In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
10.9.1.1 France Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
10.9.2 France In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
10.9.3 France In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
11 Asia Pacific In Situ Hybridization (ISH) Market Revenue and Forecasts to 2027 – Country Analysis
11.1 Asia Pacific In Situ Hybridization (ISH) Market Overview
11.2 Asia Pacific In Situ Hybridization (ISH) Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Asia Pacific In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
11.3.1 Asia Pacific Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
11.4 Asia Pacific In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
11.5 Asia Pacific In Situ Hybridization (ISH) Market Forecasts and Analysis – By End User (US$ Mn)
11.6 Asia Pacific Market Forecasts and Analysis – By Country
11.7 Japan Market Overview
11.7.1 Japan In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
11.7.1.1 Japan Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
11.7.2 Japan In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
11.7.3 Japan In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
11.8 China Market Overview
11.8.1 China In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
11.8.1.1 China Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
11.8.2 China In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
11.8.3 China In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
11.9 India Market Overview
11.9.1 India In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
11.9.1.1 India Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
11.9.2 India In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
11.9.3 India In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
12 Middle East & Africa In Situ Hybridization (ISH) Market Revenue and Forecasts to 2027 – Country Analysis
12.1 Middle East & Africa In Situ Hybridization (ISH) Market Overview
12.2 Middle East & Africa In Situ Hybridization (ISH) Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Middle East & Africa In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
12.3.1 Middle East & Africa Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
12.4 Middle East & Africa In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
12.5 Middle East & Africa In Situ Hybridization (ISH) Market Forecasts and Analysis – By End User (US$ Mn)
12.6 Middle East & Africa Market Forecasts and Analysis – By Country
12.7 South Africa Market Overview
12.7.1 South Africa In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
12.7.1.1 South Africa Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
12.7.2 South Africa In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
12.7.3 South Africa In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
12.8 Saudi Arabia Market Overview
12.8.1 Saudi Arabia In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
12.8.1.1 Saudi Arabia Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
12.8.2 Saudi Arabia In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
12.8.3 Saudi Arabia In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
12.9 UAE Market Overview
12.9.1 UAE In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
12.9.1.1 UAE Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
12.9.2 UAE In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
12.9.3 UAE In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
13 South & Central America In Situ Hybridization (ISH) Market Revenue and Forecasts to 2027 – Country Analysis
13.1 South and Central America In Situ Hybridization (ISH) Market Overview
13.2 South and Central America In Situ Hybridization (ISH) Market Revenue Forecasts and Analysis (US$ Mn)
13.3 South and Central America In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
13.3.1 South and Central America Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
13.4 South and Central America In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
13.5 South and Central America In Situ Hybridization (ISH) Market Forecasts and Analysis – By End User (US$ Mn)
13.6 South and Central America Market Forecasts and Analysis – By Country
13.7 Brazil Market Overview
13.7.1 Brazil In Situ Hybridization (ISH) Market Forecasts and Analysis – By Technology (US$ Mn)
13.7.1.1 Brazil Fluorescence In Situ Hybridization (FISH) Market Forecast and Analysis – By Type (US$ Mn)
13.7.2 Brazil In Situ Hybridization (ISH) Market Forecast and Analysis – By Application (US$ Mn)
13.7.3 Brazil In Situ Hybridization (ISH) Market Forecast and Analysis – By End User (US$ Mn)
14 Industry Landscape
14.1 Organic Growth Strategies
14.1.1 New Product Launches
14.1.2 Marketing & Promotional Activities
14.2 Inorganic Growth Strategies
14.2.1 Partnerships, Collaborations, and Joint Ventures
14.2.2 Mergers & Acquisitions
15 In Situ Hybridization (ISH) Market, Key Company Profiles
15.1 Abbott.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Overview
15.1.4 Product & Services Portfolio
15.1.5 Product Pipeline
15.1.6 SWOT Analysis
15.1.7 Key Developments
15.2 Thermofisher Scientific, Inc.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product & Services Portfolio
15.2.5 Product Pipeline
15.2.6 SWOT Analysis
15.2.7 Key Developments
15.3 PerkinElmer Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product & Services Portfolio
15.3.5 Product Pipeline
15.3.6 SWOT Analysis
15.3.7 Key Developments
15.4 Merck KGaA
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product & Services Portfolio
15.4.5 Product Pipeline
15.4.6 SWOT Analysis
15.4.7 Key Developments
15.5 F. Hoffmann-La Roche Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Overview
15.5.4 Product & Services Portfolio
15.5.5 Product Pipeline
15.5.6 SWOT Analysis
15.5.7 Key Developments
15.6 Danaher
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Overview
15.6.4 Product & Services Portfolio
15.6.5 Product Pipeline
15.6.6 SWOT Analysis
15.6.7 Key Developments
15.7 BioGenex
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product & Services Portfolio
15.7.5 Product Pipeline
15.7.6 SWOT Analysis
15.7.7 Key Developments
15.8 Bio SB
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Overview
15.8.4 Product & Services Portfolio
15.8.5 Product Pipeline
15.8.6 SWOT Analysis
15.8.7 Key Developments
15.9 Exiqon (QIAGEN)
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product & Services Portfolio
15.9.5 Product Pipeline
15.9.6 SWOT Analysis
15.9.7 Key Developments
15.10 Oxford Gene Technology
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Overview
15.10.4 Product & Services Portfolio
15.10.5 Product Pipeline
15.10.6 SWOT Analysis
15.10.7 Key Developments
16 Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
16.3 Research Methodology
The List of Companies
1. Abbott.
2. Thermofisher Scientific, Inc.
3. PerkinElmer Inc.
4. Merck KGaA
5. F. Hoffmann-La Roche Ltd
6. Danaher
7. BioGenex
8. Bio SB
9. Exiqon (QIAGEN)
10. Oxford Gene Technology
1. Abbott.
2. Thermofisher Scientific, Inc.
3. PerkinElmer Inc.
4. Merck KGaA
5. F. Hoffmann-La Roche Ltd
6. Danaher
7. BioGenex
8. Bio SB
9. Exiqon (QIAGEN)
10. Oxford Gene Technology